The role of genetic testing in prostate cancer prediction is unclear. We explain why and what you should do if you're worried about your risk of prostate cancer.
The Institute of Cancer Research has discovered a genetic mutation in samples of some men's tumours that could make them particularly susceptible to immunotherapy treatment. The researchers are now committed to running clinical trials to prove if their theory is right.
The Eastenders actor tells the Sunday Express he hid his cancer from his children for five years, but chose Father's Day to go public and warn others after speaking to us about the family risks of the disease.
We want all families to open up about the most common cancer in men this Father's Day weekend, after new stats reveal more men in the UK have – or have had – prostate cancer than ever before.
Across the papers today is news of a 'spit test' to help diagnose prostate cancer. It’s a promising step forward in genetics, but we still need better tests for diagnosis.
An international group of researchers has identified dozens more genes that are potentially involved in the growth of prostate cancer. This could lead to new ways of treating the disease.
US scientists experimenting on mice have discovered that a high-fat diet as well as genetics can determine whether localised prostate cancer spreads to other parts of the body. Dr Sophie Lutter takes an in-depth look at the science and what it could mean for men with the disease.
Our new precision medicine research programme aims to tailor treatments based on the genetic make-up of a man’s prostate cancer. The results could extend the lives of more than 9,000 men with advanced disease every year in the UK.
Deciding whether 'to treat or not to treat' localised prostate cancer is one of the biggest dilemmas for men and their doctors. Now new research from one of our Centres of Excellence could help identify which cancers are likely to spread and which are harmless.
We welcome today's reports of a new test by scientists at the University of East Anglia to determine whether a prostate cancer is aggressive or not, but the tell-tale pattern of 45 specific genes hasn't yet been proven to work for all men.